For all of the above, the study of the expression of COX-2 in the different phases of tumor progression and metastasis and the finding of new signaling pathways triggered by this enzyme are essential in order to develop new drugs that inhibit the effects of COX-2 both in cancer prevention and therapy (Rizzo, 2011). Here, PTGS2 is linked to neoplasm.